Approved indications: Riluzole is FDA-approved for the treatment of amyotrophic lateral sclerosis (ALS) in adults to extend survival and/or delay the need for tracheostomy or mechanical ventilation.

Off-label uses: Clinicians have studied and sometimes use riluzole off-label for conditions such as treatment-resistant depression, anxiety disorders, obsessive–compulsive disorder, and certain neurodegenerative or spinal cord conditions; evidence is mixed and generally limited to small trials or early-phase studies, so these uses are considered experimental and not standard care.

Efficacy expectations: Riluzole does not reverse existing weakness but can modestly slow further decline; benefits are usually assessed over months rather than days or weeks, with clinical trials showing an average survival benefit on the order of several months for the overall treated group. Compared with other ALS therapies, riluzole has a modest but well-established effect and is often used in combination with newer agents rather than alone.

Typical dosing: For adults with ALS, the usual dose is 50 mg by mouth every 12 hours (morning and evening). Different oral formulations exist (tablets, oral suspension, oral film), but they typically deliver the same 50 mg dose at the same schedule unless your prescriber gives other instructions.

How to take it: Riluzole should generally be taken on an empty stomach, at least 1 hour before or 2 hours after a meal, because high-fat food can reduce absorption. Swallow tablets whole with water; use oral suspension or oral film exactly as directed and measure liquid doses with the provided device.

Special dosing considerations: People with mild liver impairment or taking other medicines that affect the liver may need closer monitoring or dose adjustment, and use is often avoided in moderate to severe hepatic impairment. Do not change your dose or stop the medication without discussing it with your prescriber, as continuous treatment is usually needed to maintain benefit.

Missed dose: If you miss a dose, take it as soon as you remember unless it is almost time for the next dose; if so, skip the missed dose and resume your regular schedule. Do not double doses to make up for a missed one.

Overdose: In case of suspected overdose—such as taking more than the prescribed amount or if a child swallows the medicine—seek emergency medical care or contact poison control right away, as overdose can cause marked dizziness, confusion, slurred speech, or more serious nervous system and liver effects.

Common side effects: The most frequent effects include nausea, vomiting, stomach upset, diarrhea, loss of appetite, dizziness, fatigue or weakness, and elevations in liver enzymes on blood tests; these are often mild to moderate and may appear in the first weeks to months of treatment.

Serious or rare adverse effects: Riluzole can rarely cause serious liver injury (hepatitis or liver failure), marked neutropenia (very low white blood cell count), or lung problems such as interstitial lung disease. Symptoms that need immediate medical attention include yellowing of the skin or eyes, dark urine, severe or persistent nausea or vomiting, unusual tiredness, fever or sore throat that does not go away, shortness of breath, or new/worsening cough.

Warnings and precautions: Riluzole should be used cautiously or may be avoided in people with a history of significant liver disease, baseline liver enzymes more than 3 times the upper limit of normal, or heavy alcohol use. Liver function tests are recommended before starting and then periodically during treatment. Data in pregnancy are limited, so use is generally recommended only if the potential benefit justifies possible risk; breastfeeding safety is uncertain, and providers may advise avoiding breastfeeding or using an alternative. Safety and effectiveness are established mainly in adults; use in children is not routinely recommended.

Safety compared with other drugs: Overall, riluzole is considered reasonably well tolerated when liver function is monitored, but its potential for liver toxicity and rare blood or lung effects means regular follow-up is important, especially early in therapy.

Reporting side effects and safety updates: Patients in the United States can report suspected side effects to the FDA MedWatch program (online or by phone) and can review current safety communications and prescribing information on the FDA’s website or from their pharmacist or prescriber.

Drug and supplement interactions: Riluzole is broken down mainly by the liver enzyme CYP1A2, so medicines that inhibit this enzyme (such as fluvoxamine, some quinolone antibiotics like ciprofloxacin, and certain other antidepressants or anti-infectives) can raise riluzole levels and increase side-effect risk. Drugs that induce CYP1A2 (for example, some antiepileptics or rifampin) or cigarette smoking may lower riluzole levels and reduce its effect. Use caution with other medicines or supplements that can affect the liver, including high-dose acetaminophen or some herbal products.

Food, alcohol, and other interactions: High-fat meals reduce riluzole absorption, so it should be taken consistently on an empty stomach. Alcohol can add to liver strain and increase the risk of liver damage, so limiting or avoiding alcohol is usually advised while taking riluzole. No major interactions with imaging contrast agents or common diagnostic procedures are known.

Precautions and monitoring: Before and during treatment, liver function tests should be checked regularly, especially in the first 3 months and then periodically. Your clinician may also monitor blood counts if infection-like symptoms arise. Riluzole should be used with caution in people with a history of liver disease, heavy alcohol use, or in those taking multiple hepatotoxic drugs, and it is generally not recommended in significant hepatic impairment. Always provide a full list of prescription drugs, over-the-counter medicines, and supplements to your prescriber so potential interactions can be reviewed.

Q: Does riluzole cure ALS or make symptoms go away?
A: No, riluzole does not cure ALS or reverse existing weakness; it modestly slows disease progression and can extend survival for many people when taken continuously.

Q: How long does it take to know if riluzole is helping?
A: The effect of riluzole is usually seen over months rather than days or weeks, and benefit is assessed by the overall rate of decline and survival compared with what is expected without treatment.

Q: Do I have to take riluzole on an empty stomach?
A: Yes, it is generally recommended to take riluzole at least 1 hour before or 2 hours after meals, because high-fat food can reduce how much of the drug your body absorbs.

Q: What tests do I need while on riluzole?
A: Your healthcare provider will usually check blood liver function tests before starting riluzole and then periodically, especially during the first few months; additional tests may be ordered if you develop symptoms such as fever, sore throat, or breathing problems.

Q: Can I drink alcohol while taking riluzole?
A: Because both riluzole and alcohol can affect the liver, your provider will often recommend limiting or avoiding alcohol to reduce the risk of liver damage.

Storage: Store riluzole at room temperature (generally 68°F–77°F / 20°C–25°C), away from excess heat, moisture, and light, and keep the bottle tightly closed and out of reach of children and pets.

Disposal: Do not flush riluzole down the toilet or pour it down the drain unless instructed; when no longer needed or expired, use a take-back program if available or follow pharmacist or local waste guidelines for safe household trash disposal.